1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > 2016 Europe Clinical Chemistry and Immunodiagnostic Markets: Reagent and Instrument Supplier Shares, Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

2016 Europe Clinical Chemistry and Immunodiagnostic Markets: Reagent and Instrument Supplier Shares, Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

  • November 2015
  • -
  • Venture Planning Group
  • -
  • 900 pages

Summary

Table of Contents

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800.


This comprehensive five-country report contains 900 pages and 335 tables.  The report explores future trends in the European countries (France, Germany, Italy, Spain, UK); provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.


The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, and physician offices, including controls, calibrators and consumables.


Tests Analyzed in the Report Include:


Routine Clinical Chemistry


Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total, BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus, Potassium, Protein,
Total, Sodium, Triglycerides, Troponin, Uric Acid.


Therapeutic Drug Monitoring (TDM)


Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.


Endocrine Function


Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4,
TBG, Testosterone, Thyroglobulin Ab, TPO Ab, TSH.


Tumor Markers and Special Chemistry

AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid),

Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood,

PAP, PSA, Thyroglobulin, Vitamin B-12.



Immunoproteins


C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM,

Immunofixation, Prealbumin, Protein Electrophoresis.


Drugs of Abuse


Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine,

LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene,

Tricyclic Antidepressants.


Sales and Market Share Analysis


Sales and market share estimates for leading suppliers

of clinical chemistry and immunodiagnostic products

by country and individual product.


Geographic Regions


- France

- Germany

- Italy

- Spain

- UK


Competitive Assessments


Strategic assessments of major suppliers and

emerging market entrants, including their sales,

product portfolios, marketing tactics, and new products in R&D.


Market Segmentation Analysis


- Comprehensive market segmentation

  analysis, including review of the market

  dynamics, trends, structure, size, growth,

  and key suppliers, by country.


- Test volume and sales forecasts for over 100 clinical chemistry,

  TDM, endocrine, cancer, immunoprotein and abused drug assays,

   by country and market segment:


     - Hospitals

     - Commercial/Private Laboratories

     - Physician Offices/Group Practices

     - Ambulatory Care Centers


Current and Emerging Products


- Analysis of current and emerging clinical chemistry

  and immunodiagnostic tests.


- Review of current instrumentation technologies, and a feature comparison

  of high-, medium-, and low-volume/POC analyzers.


Technology Review


- Assessment of current and emerging

  technologies, and their potential  market applications.


- Comprehensive lists of companies developing

  or marketing new technologies and products by test.


Strategic Recommendations


- New product development opportunities

  with significant market appeal.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.

                                                                             

Contains 900 pages and 335 tables

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


Download Unlimited Documents from Trusted Public Sources

Opioid Market and Digestive System Disorder Statistics in the US

  • April 2017
    20 pages
  • Opioid  

    Digestive Syste...  

  • United States  

View report >

Therapy Market in the US

  • April 2017
  • Therapy  

  • United States  

View report >

Therapy Market and Targeted Therapy Market in the UK

  • April 2017
    77 pages
  • Therapy  

    Targeted Therap...  

    Digestive Syste...  

  • United Kingdom  

View report >

Cranberry Industry

13 days ago

Diabetes Statistics

17 days ago

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.